Literature DB >> 15458603

Poloxamer 188 volumetrically decreases neuronal loss in the rat in a time-dependent manner.

Daniel J Curry1, David A Wright, Raphael C Lee, Un Jung Kang, David M Frim.   

Abstract

OBJECTIVE: Excitotoxicity is a multistep process that results in either necrosis or apoptosis. It has been associated with neuronal death in trauma, ischemia, and neurodegeneration. The final step in necrotic cell death is the rupture of a cell's plasma membrane; repair of this membrane rupture is a potentially powerful technique of neuroprotection. Poloxamer 188 (P-188) is a synthetic surfactant that seals experimentally porated membranes. This study investigated the usefulness and time dependence of intrathecal P-188 in protecting neurons in an in vivo model of excitotoxicity in the rat.
METHODS: Twenty-eight Sprague-Dawley rats underwent striatal infusion of quinolinic acid to produce a spherical excitotoxic lesion. Each animal then received either vehicle or P-188 at 10 minutes, 4 hours, or both time points after surgery by direct cisterna magna injection. Animals were killed at 1 week, and brains were stained immunohistochemically for the neuronal marker Neu-N. Volumes of neuronal loss were calculated and compared between groups by analysis of variance.
RESULTS: All animals were found to have spherical, stereotyped lesions. The animals that received intrathecal poloxamer at the early injection time had statistically smaller lesions (8.16 +/- 6.12 mm(3); n = 5; P = 0.0015) than controls (18.25 +/- 11.42 mm(3); n = 11). Those animals that received poloxamer at both injection times also had statistically smaller lesions (10.57 +/- 9.00 mm(3); n = 7; P = 0.0095). The group that received poloxamer at the late injection time only did not have significantly decreased lesion size (14.86 +/- 7.95 mm(3); n = 5).
CONCLUSION: Intrathecal P-188 reduces neuronal loss after excitotoxic injury in the rat only when delivered immediately after the toxin. This observation confirms the potential of surfactant molecules as neuroprotectants but predicts that their usefulness is best realized by early and potentially ongoing treatment.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15458603     DOI: 10.1227/01.neu.0000137890.29862.2c

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  5 in total

Review 1.  Advances in neuroprotective strategies: potential therapies for intracerebral hemorrhage.

Authors:  Brian Y Hwang; Geoffrey Appelboom; Amit Ayer; Christopher P Kellner; Ivan S Kotchetkov; Paul R Gigante; Raqeeb Haque; Michael Kellner; E Sander Connolly
Journal:  Cerebrovasc Dis       Date:  2010-12-21       Impact factor: 2.762

2.  Poloxamer 188 Attenuates Cerebral Hypoxia/Ischemia Injury in Parallel with Preventing Mitochondrial Membrane Permeabilization and Autophagic Activation.

Authors:  Chengliang Luo; Qianqian Li; Yuan Gao; Xi Shen; Lu Ma; Qiong Wu; Zufeng Wang; Mingyang Zhang; Ziqin Zhao; Xiping Chen; Luyang Tao
Journal:  J Mol Neurosci       Date:  2015-05-13       Impact factor: 3.444

3.  Kollidon VA64, a membrane-resealing agent, reduces histopathology and improves functional outcome after controlled cortical impact in mice.

Authors:  Lamin H Mbye; Eyup Keles; Luyang Tao; Jimmy Zhang; Joonyong Chung; Mykol Larvie; Rajani Koppula; Eng H Lo; Michael J Whalen
Journal:  J Cereb Blood Flow Metab       Date:  2011-11-16       Impact factor: 6.200

4.  Mechanical membrane injury induces axonal beading through localized activation of calpain.

Authors:  Devrim Kilinc; Gianluca Gallo; Kenneth A Barbee
Journal:  Exp Neurol       Date:  2009-07-18       Impact factor: 5.330

5.  Poloxamer 188 protects neurons against ischemia/reperfusion injury through preserving integrity of cell membranes and blood brain barrier.

Authors:  Jin-Hua Gu; Jian-Bin Ge; Mei Li; Hai-Dong Xu; Feng Wu; Zheng-Hong Qin
Journal:  PLoS One       Date:  2013-04-16       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.